The report highlights Hanmi Pharm's commitment to sustainable management practices, including its focus on R&D, customer satisfaction, ethics, talent management, and environmental, health, and safety (EHS) performance. The company also emphasizes its commitment to social responsibility through donations, volunteer activities, and support for the healthcare industry. Notable highlights include the company's third CSR report, the achievement of ISO22301 certification for its Business Continuity Management System (BCMS), and the continued success of its 'Korean R&D Model' in developing new drugs. The report also includes information on the company's affiliated companies, Beijing Hanmi Pharmaceutical Company and Hanmi Fine Chemical Company.
Issuing Company Hanmi Pharm. Co., Ltd.
Report Type Sustainability Report
Report Language EN
Report Filesize 4.76 MB
No. of Pages 51 pages
Reporting periodJanuary 01, 2019 to December 31, 2019
Report Edition3
Assurance Provider Korea Standards Association
Reporting Standards GRI: Core Option; AA1000 Assurance Standard
Materiality Assessmenttrue